Jenny Sundqvist
Chief Executive Officer en INDEX PHARMACEUTICALS HOLDING AB .
Perfil
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Cargos activos de Jenny Sundqvist
| Empresas | Cargo | Inicio |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01/01/2023 |
Antiguos cargos conocidos de Jenny Sundqvist.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2021 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Formación de Jenny Sundqvist.
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
- Bolsa de valores
- Insiders
- Jenny Sundqvist
